Telemedicine
DeviceMonitoring and control is performed through telematics platform integrated management of chronic NOMHAD, configurated to respond the patients specific needs.
NCT Number: NCT02943538
Pragmatic clinical trial, randomized, controlled parallel, 3 group (group technology platform, call group and control group), developed in the monograph Reference Unit of Inflammatory Bowel Disease Valencia (single-center).
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Hypothesis: The interventions follow-up of patients with Crohn's Disease or Ulcerative Colitis active moderate-high complexity based on the incorporation of information technologies and communication, to improve monitoring of the presence of inflammatory activity, adherence to treatment and drug toxicity, increase the proportion of inactive patients (clinical remission) at 6 months follow-up and thus improve clinical outcomes and health outcomes (HRQOL, satisfaction) and reduces the consumption of health resources.
Goals:
Description:
The proposed intervention is based on the extent of chronic GeCronic program that is currently being developed at the Hospital La Fe de Valencia for comprehensive management of chronic conditions of high complexity using the technology platform NOMHAD. NOMHADchronic is a system designed to allow management services to deploy chronically ill supported by technology. The product consists of different modules that seek to cover all aspects of that management: clinical information on the status of patients according to their respective conditions, support for the coordination of the actors during the care process, logistics management and human resources, integration with accessories and monitoring devices. Of all the modules of the platform, NOMHADcore out as the module which houses all the functionality on clinical and care management of patients. There follows a detailed description of the module, its structure and operation.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Monitoring and control is performed through telematics platform integrated management of chronic NOMHAD, configurated to respond the patients specific needs.
A telephone control of their state and evolution will be made through the nursing staff of the unit.
Conventional care provided in the unit to patients with IBD -high moderate complexity.
Time frame: 6 months
Clinical remission of patients at 6 months of follow-up using Harvey-Bradshaw index for Crohn's disease.
Time frame: 6 months
Clinical remission of patients at 6 months of follow-up using May index for ulcerative colitis.
Time frame: 6 months
Health-Related Quality of Life measured by the generic Euroqol (EQ-5D) questionaire
Time frame: 6 months
Health-Related Quality of Life measured by the specific IBD in its reduced version (SIBDQ: Short Inflammatory Bowel Disease Questionnaire).
Time frame: 6 months
Measured by a satisfaction questionaire designed for the study.
Time frame: 6 months
Measured by the validated Morisky-Green questionaire.
Time frame: 6 months
Urgent and scheduled visits and urgent hospital admissions in the follow-up period will be captured directly systems hospital information (HIS).
Time frame: 6 months
Time frame: 6 months
Worrk activity and productivity measured by a validate questionaire: Vergara M. et al. Value Health 2011;14(6):859-61).
Time frame: 6 months
Time frame: 6 months
Instituto de Investigacion Sanitaria La Fe
Other
Clinical Impact of Telemedicine in Crohn's Disease and Ulcerative Colitis: Study Teccu
Acronym: TECCU
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02620046
Colitis, Colitis, Ulcerative
Phoenix, Arizona, United States
View Trial DetailsNCT02678052
Colitis, Colitis, Ulcerative
San Diego, California, United States
View Trial DetailsNCT03662919
Ankylosis, Arthritis
Caluire-et-Cuire, Auvergne-Rhône-Alpes, France
View Trial DetailsNCT02559713
Behavior, Breast Feeding
Aurora, Colorado, United States
View Trial Details